163 related articles for article (PubMed ID: 11825008)
1. Empirical monotherapy with meropenem in serious bacterial infections in children.
Hsu HL; Lu CY; Tseng HY; Lee PI; Lai HP; Lin WC; Hsieh YC; Lee CY; Huang LM
J Microbiol Immunol Infect; 2001 Dec; 34(4):275-80. PubMed ID: 11825008
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
[TBL] [Abstract][Full Text] [Related]
3. Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients.
Kuo BI; Fung CP; Liu CY
Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):361-7. PubMed ID: 10862445
[TBL] [Abstract][Full Text] [Related]
4. Carbapenems in paediatrics.
Blumer JL
Scand J Infect Dis Suppl; 1995; 96():38-44. PubMed ID: 7652502
[TBL] [Abstract][Full Text] [Related]
5. Update on the efficacy and tolerability of meropenem in the treatment of serious bacterial infections.
Mohr JF
Clin Infect Dis; 2008 Sep; 47 Suppl 1():S41-51. PubMed ID: 18713049
[TBL] [Abstract][Full Text] [Related]
6. Empirical monotherapy with meropenem in serious bacterial infections. Meropenem Study Group.
Mouton YJ; Beuscart C
J Antimicrob Chemother; 1995 Jul; 36 Suppl A():145-56. PubMed ID: 8543490
[TBL] [Abstract][Full Text] [Related]
7. Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.
Colardyn F; Faulkner KL
J Antimicrob Chemother; 1996 Sep; 38(3):523-37. PubMed ID: 8889726
[TBL] [Abstract][Full Text] [Related]
8. A randomized, controlled clinical trial on meropenem versus imipenem/cilastatin for the treatment of bacterial infections.
Hou F; Li J; Wu G; Zheng B; Chen Y; Gu J; Wang H; Huo L; Xue X; Jia C; Yin Y; Tian X; Ren S
Chin Med J (Engl); 2002 Dec; 115(12):1849-54. PubMed ID: 12622937
[TBL] [Abstract][Full Text] [Related]
9. Meropenem compared with ceftazidime in the empiric treatment of acute severe infections in hospitalized children. Italian Pediatric Meropenem Study Group.
Principi N; Marchisio P
J Chemother; 1998 Apr; 10(2):108-13. PubMed ID: 9603635
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of effectiveness and safety of generic formulation of meropenem for treatment of infections at Siriraj Hospital.
Angkasekwinai N; Werarak P; Chaiyasoot K; Thamlikitkul V
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S217-24. PubMed ID: 21721450
[TBL] [Abstract][Full Text] [Related]
11. Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors.
Oguz A; Karadeniz C; Citak EC; Cil V; Eldes N
Pediatr Hematol Oncol; 2006; 23(3):245-53. PubMed ID: 16517540
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of meropenem as an empirical treatment for febrile neutropenia in children with cancer.
Pancharoen C; Mekmullica J; Buranachonapa J; Trongjit D; Nuchprayoon I; Vanichsetakul P; Seksarn P; Thisyakorn U
J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S174-8. PubMed ID: 12929986
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the efficacy and safety of isepamicin in the treatment of various bacterial infections.
Petrikkos G; Giamarellou H; Tsagaraki C; Pefanis A
J Chemother; 1995 Jun; 7 Suppl 2():161-4. PubMed ID: 8622106
[TBL] [Abstract][Full Text] [Related]
14. Meropenem in the treatment of febrile neutropenic children.
Müller J; Garami M; Constantin T; Schmidt M; Fekete G; Kovács G
Pediatr Hematol Oncol; 2005 Jun; 22(4):277-84. PubMed ID: 16020114
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.
LeFrock JL; Smith BR; Chandrasekar P; Rolston KV; Molavi A; Kannangara W
Arch Intern Med; 1987 Feb; 147(2):325-8. PubMed ID: 3813751
[TBL] [Abstract][Full Text] [Related]
16. Meropenem.
Shah D; Narang M
Indian Pediatr; 2005 May; 42(5):443-50. PubMed ID: 15923690
[TBL] [Abstract][Full Text] [Related]
17. Meropenem use and colonization by antibiotic-resistant Gram-negative bacilli in a pediatric intensive care unit.
Toltzis P; Dul M; O'Riordan MA; Melnick D; Lo M; Blumer J
Pediatr Crit Care Med; 2009 Jan; 10(1):49-54. PubMed ID: 19057450
[TBL] [Abstract][Full Text] [Related]
18. [Clinical pharmacology and indications of meropenem in severe pediatric infection].
Honorato J; Sádaba B; Díaz M
Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():38-44. PubMed ID: 9410068
[TBL] [Abstract][Full Text] [Related]
19. Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.
Arguedas A; Cespedes J; Botet FA; Blumer J; Yogev R; Gesser R; Wang J; West J; Snyder T; Wimmer W;
Int J Antimicrob Agents; 2009 Feb; 33(2):163-7. PubMed ID: 18945594
[TBL] [Abstract][Full Text] [Related]
20. [Ceftazidime in common infections in childhood. Experience in 262 cases].
Fanos V; Fostini R; Panebianco R; Danieli D
Clin Ter; 1991 Jun; 137(5):327-32. PubMed ID: 1832605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]